title: Vaccine against toxic shock syndrome in a first-in-man clinical trial.
authors.affiliation: a Biomedizinische ForschungsgmbH , Vienna , Austria.
authors.forename: Andreas
authors.initials: A
authors.lastname: Roetzer
authors.affiliation: b Department of Clinical Pharmacology , Medical University of Vienna , Vienna , Austria.
authors.forename: Bernd
authors.initials: B
authors.lastname: Jilma
authors.affiliation: a Biomedizinische ForschungsgmbH , Vienna , Austria.
authors.forename: Martha M
authors.initials: MM
authors.lastname: Eibl
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D012772:Shock, Septic / Q000517:prevention & control*; D013203:Staphylococcal Infections / Q000150:complications*; D013209:Staphylococcal Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology*; D014612:Vaccines; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology
chemical_list: D013209:Staphylococcal Vaccines; D014612:Vaccines; D014614:Vaccines, Synthetic
keywords: Staphylococcus aureus; bacterial infection; first-in-man clinical trial; toxic shock syndrome; toxoid vaccine